Risk factors for medication non-adherence among atrial fibrillation patients

[1]  D. Singer,et al.  Health Literacy and Awareness of Atrial Fibrillation , 2017, Journal of the American Heart Association.

[2]  S. Pandi-Perumal,et al.  Nonadherence to antihypertensive medications in adults with high risk for obstructive sleep apnea , 2017, Journal of clinical hypertension.

[3]  R. Shruthi,et al.  A Study of Medication Compliance in Geriatric Patients with Chronic Illnesses at a Tertiary Care Hospital. , 2016, Journal of clinical and diagnostic research : JCDR.

[4]  M. Rienstra,et al.  Rate control in atrial fibrillation , 2016, The Lancet.

[5]  M. Rienstra,et al.  Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study). , 2016, American heart journal.

[6]  V. Auyeung,et al.  Adherence to long‐term anticoagulation treatment, what is known and what the future might hold , 2016, British journal of haematology.

[7]  F. Al-Khalili,et al.  Adherence to anticoagulant treatment with apixaban and rivaroxaban in a real-world setting , 2016 .

[8]  M. Jaffe,et al.  The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013) , 2016, Journal of clinical hypertension.

[9]  T. Chao,et al.  Rate-Control Treatment and Mortality in Atrial Fibrillation , 2015, Circulation.

[10]  D. Wetter,et al.  Health Literacy, Smoking, and Health Indicators in African American Adults , 2015, Journal of health communication.

[11]  S. Peiró,et al.  Adherence to oral anticoagulants in patients with atrial fibrillation—a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol , 2015, BMJ Open.

[12]  T. Sunderland,et al.  Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink. , 2015, Thrombosis research.

[13]  E. Prystowsky,et al.  Treatment of atrial fibrillation: a weighty problem. , 2015, Journal of the American College of Cardiology.

[14]  F. Skjøth,et al.  Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study , 2015, Journal of thrombosis and haemostasis : JTH.

[15]  C. Gumbinger,et al.  Reasons Underlying Non-Adherence to and Discontinuation of Anticoagulation in Secondary Stroke Prevention among Patients with Atrial Fibrillation , 2015, European Neurology.

[16]  G. Grunwald,et al.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. , 2014, American heart journal.

[17]  B. Steinberg,et al.  Anticoagulation in atrial fibrillation , 2014, BMJ : British Medical Journal.

[18]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[19]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[20]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[21]  J. Chen,et al.  Utilization of antibacterials in inpatients and analysis of bacterial drug resistance of the Fifth Hospital Affiliated to the Xinjiang Medical University from 2007 to 2011 , 2013 .

[22]  A. Go,et al.  Improved blood pressure control associated with a large-scale hypertension program. , 2013, JAMA.

[23]  E. Buysman,et al.  Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population. , 2013, Clinical therapeutics.

[24]  J. Eikelboom,et al.  Adherence to anticoagulant treatment with dabigatran in a real‐world setting , 2013, Journal of thrombosis and haemostasis : JTH.

[25]  Daniel E. Singer,et al.  A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score , 2013, Journal of the American Heart Association.

[26]  K. Coleman,et al.  Race and Ethnicity Data Quality and Imputation Using U.S. Census Data in an Integrated Health System , 2013, Medical care research and review : MCRR.

[27]  J. Schein,et al.  One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events , 2013, Journal of managed care pharmacy : JMCP.

[28]  S. Mody,et al.  Burden of comorbidities among patients with atrial fibrillation , 2013, Therapeutic advances in cardiovascular disease.

[29]  J. Broderick,et al.  Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence , 2011, Stroke.

[30]  Marie T. Brown,et al.  Medication adherence: WHO cares? , 2011, Mayo Clinic proceedings.

[31]  Mark D. Huffman,et al.  Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association , 2011, Circulation.

[32]  P. Muntner,et al.  Health-related quality of life and antihypertensive medication adherence among older adults. , 2010, Age and ageing.

[33]  Steven Baroletti,et al.  Medication Adherence in Cardiovascular Disease , 2010, Circulation.

[34]  Gani Bajraktari,et al.  Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study. , 2010, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[35]  A. Localio,et al.  Risk factors for nonadherence to warfarin: results from the IN‐RANGE study , 2008, Pharmacoepidemiology and drug safety.

[36]  Siamak Noorbaloochi,et al.  Validation of Screening Questions for Limited Health Literacy in a Large VA Outpatient Population , 2008, Journal of General Internal Medicine.

[37]  Jing Jin,et al.  Factors affecting therapeutic compliance: A review from the patient’s perspective , 2008, Therapeutics and clinical risk management.

[38]  B. Svarstad,et al.  Relationships between multiple self-reported nonadherence measures and pharmacy records. , 2007, Research in social & administrative pharmacy : RSAP.

[39]  Jay Hawkshead,et al.  Techniques for Measuring Medication Adherence in Hypertensive Patients in Outpatient Settings , 2007 .

[40]  F. Smith,et al.  Effective chronic disease management: patients' perspectives on medication-related problems. , 2007, Patient education and counseling.

[41]  B. Psaty,et al.  Newly detected atrial fibrillation and compliance with antithrombotic guidelines. , 2007, Archives of internal medicine.

[42]  Robert Gross,et al.  The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. , 2007, Archives of internal medicine.

[43]  Barry D. Weiss,et al.  Brief Report: screening items to identify patients with limited health literacy skills , 2006, Journal of General Internal Medicine.

[44]  D. Holdford,et al.  Predictors of Noncompliance with Warfarin Therapy in an Outpatient Anticoagulation Clinic , 2005, Pharmacotherapy.

[45]  M. Whooley,et al.  Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. , 2005, Archives of internal medicine.

[46]  S. Kripalani,et al.  Identifying and Assisting Low-Literacy Patients with Medication Use: A Survey of Community Pharmacies , 2005, The Annals of pharmacotherapy.

[47]  B. Gage,et al.  Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.

[48]  E. Boyko,et al.  Brief questions to identify patients with inadequate health literacy. , 2004, Family medicine.

[49]  A. Majeed,et al.  Comorbidity associated with atrial fibrillation: a general practice-based study. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[50]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[51]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[52]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[53]  P. Savage,et al.  Cardiovascular risk factors in young adults: The CARDIA baseline monograph , 1991 .

[54]  Lizheng Shi,et al.  Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review , 2017, PharmacoEconomics.

[55]  Teresa Y. Lin,et al.  The Kaiser Permanente Northern California Adult Member Health Survey. , 2016, The Permanente journal.

[56]  Jeffrey M. Ashburner,et al.  Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). , 2015, The American journal of cardiology.

[57]  Michael K Gould,et al.  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. , 2012, The Permanente journal.

[58]  G. W. Gribble.  Occurrence. , 2010, Fortschritte der Chemie organischer Naturstoffe = Progress in the chemistry of organic natural products. Progres dans la chimie des substances organiques naturelles.

[59]  Mahendra Patel,et al.  Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence , 2009 .